Arca Biopharma | ABIO - Current Assets


Arca Biopharma reported $884.56M in Current Assets for its fiscal quarter ending in June of 2026.





Current Assets Change Date
Alterity Therapeutics Limited AUD 37.91M 15.92M Dec/2025
Amgen USD 34.96B 3.49B Jun/2026
Arca Biopharma USD 884.56M 489.31M Jun/2026
Biogen USD 7.31B 1.88B Jun/2026
Brainstorm Cell Therapeutics USD 316K 132K Jun/2026
Bristol-Myers Squibb USD 28.58B 1.37B Jun/2026
Capricor Therapeutics USD 242.13M 40.96M Jun/2026
Cipla INR 241.47B 7.71B Mar/2026
Clal Biotechnology ILS 14.69M 1.95M Dec/2023
Compugen USD 137.28M 10.74M Mar/2026
CSL USD 11.85B 1000K Dec/2025
Cytokinetics USD 1.21B 369.02M Jun/2026
Daiichi Sankyo JPY 2.23T 91.92B Jun/2026
Gilead Sciences USD 12.53B 6.11B Jun/2026
GlaxoSmithKline GBP 17.56B 202M Jun/2026
Grifols EUR 5.96B 316.31M Dec/2025
Laboratory Of America USD 3.81B 743.9M Jun/2026
Myriad Genetics USD 289M 23.8M Jun/2026
Otsuka Holdings JPY 1.63T 30.58B Jun/2026
Pfizer USD 41.36B 1.46B Jun/2026
United Therapeutics USD 3.48B 611.7M Jun/2026